Literature DB >> 19340413

Mammalian epoxide hydrolases in xenobiotic metabolism and signalling.

Martina Decker1, Michael Arand, Annette Cronin.   

Abstract

Epoxide hydrolases catalyse the hydrolysis of electrophilic--and therefore potentially genotoxic--epoxides to the corresponding less reactive vicinal diols, which explains the classification of epoxide hydrolases as typical detoxifying enzymes. The best example is mammalian microsomal epoxide hydrolase (mEH)-an enzyme prone to detoxification-due to a high expression level in the liver, a broad substrate selectivity, as well as inducibility by foreign compounds. The mEH is capable of inactivating a large number of structurally different, highly reactive epoxides and hence is an important part of the enzymatic defence of our organism against adverse effects of foreign compounds. Furthermore, evidence is accumulating that mammalian epoxide hydrolases play physiological roles other than detoxification, particularly through involvement in signalling processes. This certainly holds true for soluble epoxide hydrolase (sEH) whose main function seems to be the turnover of lipid derived epoxides, which are signalling lipids with diverse functions in regulatory processes, such as control of blood pressure, inflammatory processes, cell proliferation and nociception. In recent years, the sEH has attracted attention as a promising target for pharmacological inhibition to treat hypertension and possibly other diseases. Recently, new hitherto uncharacterised epoxide hydrolases could be identified in mammals by genome analysis. The expression pattern and substrate selectivity of these new epoxide hydrolases suggests their participation in signalling processes rather than a role in detoxification. Taken together, epoxide hydrolases (1) play a central role in the detoxification of genotoxic epoxides and (2) have an important function in the regulation of physiological processes by the control of signalling molecules with an epoxide structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340413     DOI: 10.1007/s00204-009-0416-0

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  63 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

Review 2.  Role of epoxide hydrolases in lipid metabolism.

Authors:  Christophe Morisseau
Journal:  Biochimie       Date:  2012-06-18       Impact factor: 4.079

3.  Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.

Authors:  Peng Zhang; Youzhi Zhang; Haihua Yang; Wenjing Li; Xiaodong Chen; Feng Long
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.

Authors:  Mona Fathy; Mai Hamed; Omnia Youssif; Nahla Fawzy; Wafa Ashour
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

5.  A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Kasem Nithipatikom; Michael P Endsley; Adam W Pfeiffer; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2014-06-23       Impact factor: 5.922

6.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

Review 7.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Authors:  Siwen Wang; Jie Zhu; Ruxin Zhang; Siyang Wang; Zongheng Gu
Journal:  Tumour Biol       Date:  2013-02-03

8.  Optimization of antitumor modulators of pre-mRNA splicing.

Authors:  Chandraiah Lagisetti; Gustavo Palacios; Tinopiwa Goronga; Burgess Freeman; William Caufield; Thomas R Webb
Journal:  J Med Chem       Date:  2013-12-11       Impact factor: 7.446

9.  EPHX1 rs2234922 polymorphism and lung cancer susceptibility in Asian populations: a meta-analysis.

Authors:  Xuefang Xu; Hongxia Hua; Bing Fan; Qing Sun; Xuedan Guo; Jiawei Zhang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 10.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.